|
|
George R. Bailie, Pharm.D., PhD
Professor
Department of Pharmacy Practice
Education:
Pharm.D., University of Minnesota
Ph.D.,
University of Wales
Courses Taught at ACP:
Nephrology in PT4.
Research Interests:
Optimization of medication use in kidney disease.
Recent Publications:
Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, Combe C, Rayner HC, Saito A, Gillespie BW, Young EW. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005, 45: 119-126.
Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, Wolfe R, Port F, Burrows-Hudson S, Saran R. Patterns of medication use in the RRI-CKD Study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005;20:1110-1115.
Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant 2005;20:1443-1449.
Elwell RJ, Manley HJ, Frye RF, Bailie GR. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients. Int J Artif Organs 2006;28:808-816.
Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saiyo A, Bragg-Gresham JL, Gillespie BW, Young EW. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study. Hemodialysis Int 2006;10:180-188.
Other (patent, textbook, clinical affiliations, etc.):
Adjunct Faculty, Division of Nephrology, AMC